These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16043673)

  • 1. Goldilocks and menopause.
    Vigersky RA
    Arch Intern Med; 2005 Jul; 165(14):1571-2. PubMed ID: 16043673
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Libido loss after total surgery. Testosterone patch increases sexual desire].
    Schwenkhagen A
    MMW Fortschr Med; 2006 Nov; 148(47):48-9. PubMed ID: 17168190
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
    Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA
    Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of hypoactive sexual desire disorder.
    Amato P; Buster JE
    Clin Obstet Gynecol; 2009 Dec; 52(4):666-74. PubMed ID: 20393418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone supplementation to improve women's sexual satisfaction: complexities and unknowns.
    Basson R
    Ann Intern Med; 2008 Apr; 148(8):620-1. PubMed ID: 18413624
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G; Eden JA; Manga RZ
    Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose?
    Reynolds PL
    J Fam Pract; 2000 Dec; 49(12):1148. PubMed ID: 11132065
    [No Abstract]   [Full Text] [Related]  

  • 13. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application.
    Raza S; Baig M; Ali J; Rizvi S
    Int J Impot Res; 2008; 20(2):226-8. PubMed ID: 17851581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What will become of Intrinsa?].
    Nau JY
    Rev Med Suisse; 2005 Mar; 1(12):857. PubMed ID: 15865362
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoactive sexual desire disorder in postmenopausal women.
    Nappi RE; Wawra K; Schmitt S
    Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on "Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial" by Dr Ko and colleagues.
    Pae CU
    J Clin Psychopharmacol; 2009 Apr; 29(2):194-5; author reply 196-7. PubMed ID: 19512992
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
    Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study.
    Gleicher N; Barad DH
    Hum Reprod; 2006 Nov; 21(11):3027; author reply 3027-8. PubMed ID: 17035548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.